首页> 外文期刊>Expert opinion on therapeutic targets >Fibroblast activation protein-alpha in fibrogenic disorders and cancer: more than a prolyl-specific peptidase?
【24h】

Fibroblast activation protein-alpha in fibrogenic disorders and cancer: more than a prolyl-specific peptidase?

机译:成纤维细胞活化蛋白-α在纤维纤维疾病和癌症中:多于脯氨酰肽酶?

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction: Fibroblast activation protein-alpha (FAP-alpha) belongs to the family of prolyl-specific serine proteases. FAP-alpha displays both exopeptidase and endopeptidase/gelatinase/collagenase activities. FAP-alpha protein and/or activity have been associated with fibrosis, inflammation and cancer, but the protein is undetectable in most normal tissues. FAP-alpha is selectively expressed at sites of tissue remodeling and repair and enhances tumor progression, suggesting that this protease may be a therapeutic target to treat human disorders associated with fibrotic dysregulation.
机译:引言:成纤维细胞活化蛋白-α(FAP-α)属于含有含量特异性丝氨酸蛋白酶的系列。 FAP-α显示外肽酶和内肽酶/凝胶酶/胶原酶活性。 FAP-α蛋白和/或活性与纤维化,炎症和癌症有关,但在大多数正常组织中蛋白质是不可检测的。 FAP-α在组织重塑和修复的部位选择性地表达并增强肿瘤进展,表明该蛋白酶可以是治疗与纤维化多粒细胞相关的人类疾病的治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号